Novartis

German Doctors Stand by MS Drugs Despite Warning

Roche Alzheimer's Drug Fails Main Goals in Mid-stage Study

Novartis and Banner in Alzheimer’s Genetic Predisposal Study

Former Novartis Employee Suspected of Data Manipulation

GSK Invites Private Equity Bids for Older Drugs

Topics • Strategy

International Drugmakers Meet Challenges

Bayer to Pay $14.2 Billion for U.S. Merck’s Consumer Business

Topics • Logistics

Simplify Planning Processes

Bayer and Reckitt Said Finalists for Merck & Co. Consumer Arm

Christophe Vidonne and Dr. Ralph Billo about Novartis' Buffer Management Concept

LEAN Supply Chain Planning

Novartis and Lilly Clinch Animal Health Deal

Novartis and GlaxoSmithKline Swap $20 Billion in Assets

Teva Asks U.S. Supreme Court to Stay Copaxone Ruling

Novartis Replaces Top Management in Japan After Clinical Trials Probe

Novartis Ends Heart Failure Drug Tests Early on Strong Results

U.S. Justices Agree to Hear Teva's Copaxone Appeal

Codexis Reports Fourth Quarter and Full Year 2013 Results

Bayer, Novartis said to Eye Merck & Co consumer health unit

Novartis Acquires U.S. Cancer Specialist CoStim

Swiss Anti-Immigration Vote Could Impact Chemical Sector

Novartis Said to Be Mulling a Jobs Shift to India

Fourth Ranbaxy Generics Plant Hit by FDA Ban

J&J Petitions FDA to Require ‘Similar’ Names For Biosimilars, Biologics

Bayer’s Eylea AMD Drug Hits Cost Evaluation Hurdle

EU Fines Drugmakers €16 million for Painkiller Delay

Boehringer Unit Taps Bank of America to Explore Sale of Generics Business

Novartis Overhauls Japanese Unit after Drug Scandal

Astrazeneca CEO Gets Two Cheers after First Year in Job

Syngenta May Be Template as Novartis Reviews Non-Core Assets

Novartis to Investigate Bribery Claims at Alcon Unit in China

China to Launch Fresh Pharmaceutical Bribery Probe

India Revokes GSK Cancer Drug Patent In Latest Big Pharma Blow

Europe Backs New Dual-Action Novartis Lung Drug

Bexsero Setback hits Novartis’ Vaccine Division

124 more articles

Top-Feature

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Predictive Simulation in Pharma Production

Expert Insights

ADCs for Precision Cancer Therapy

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.